BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBT
2876
DELISTED
Welbilt, Inc.
WBT
| $112K | ﹤0.01% |
4,826
-41,951
| -90% | -$890K |
|
|
BMTC
2877
DELISTED
Bryn Mawr Bank Corp
BMTC
| $111K | ﹤0.01% |
2,640
-6,138
| -70% | -$281K |
|
2878
Comstock Resources
CRK
$3.99B
| $111K | ﹤0.01% |
16,694
+2,742
| +20% | +$15.8K |
|
|
SAGE
2879
DELISTED
Sage Therapeutics
SAGE
| $111K | ﹤0.01% |
1,959
+1,688
| +623% | +$119K |
|
|
ALLK
2880
DELISTED
Allakos
ALLK
| $111K | ﹤0.01% |
1,303
-2,064
| -61% | -$206K |
|
|
FBMS
2881
DELISTED
The First Bancshares, Inc.
FBMS
| $111K | ﹤0.01% |
2,965
-6,856
| -70% | -$264K |
|
2882
Fortis
FTS
$28.8B
| $111K | ﹤0.01% |
2,500
| – | – |
|
2883
Vanguard FTSE Emerging Markets ETF
VWO
$126B
| $110K | ﹤0.01% |
2,030
-68,479
| -97% | -$3.65M |
|
|
WTRE
2884
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $110K | ﹤0.01% |
3,147
-5,151
| -62% | -$180K |
|
2885
1st Source
SRCE
$2.13B
| $110K | ﹤0.01% |
2,368
-4,930
| -68% | -$236K |
|
|
NSTG
2886
DELISTED
NanoString Technologies, Inc.
NSTG
| $110K | ﹤0.01% |
1,695
-5,104
| -75% | -$324K |
|
2887
Lands' End
LE
$390M
| $110K | ﹤0.01% |
2,670
-2,485
| -48% | -$67.9K |
|
2888
PTC Therapeutics
PTCT
$6.01B
| $110K | ﹤0.01% |
2,591
-5,312
| -67% | -$228K |
|
2889
Barnes & Noble Education
BNED
$424M
| $109K | ﹤0.01% |
151
+93
| +160% | +$75K |
|
2890
Future Fuel
FF
$249M
| $108K | ﹤0.01% |
11,267
-2,723
| -19% | -$32.9K |
|
|
ITCI
2891
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $108K | ﹤0.01% |
2,648
-17,668
| -87% | -$653K |
|
2892
ArcelorMittal
MT
$55.2B
| $107K | ﹤0.01% |
+3,438
| New | +$106K |
|
2893
Eldorado Gold
EGO
$10B
| $106K | ﹤0.01% |
10,672
-1,948
| -15% | -$21.7K |
|
|
MRTX
2894
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $105K | ﹤0.01% |
651
-4,896
| -88% | -$786K |
|
2895
Horizon Bancorp
HBNC
$1.05B
| $105K | ﹤0.01% |
6,031
-14,467
| -71% | -$264K |
|
2896
Univest Financial
UVSP
$1.19B
| $105K | ﹤0.01% |
3,981
-8,775
| -69% | -$246K |
|
2897
Rhythm Pharmaceuticals
RYTM
$7.99B
| $104K | ﹤0.01% |
5,297
-9,437
| -64% | -$196K |
|
|
RADA
2898
DELISTED
Rada Electronic Industries Ltd
RADA
| $103K | ﹤0.01% |
8,464
| – | – |
|
2899
CALL
C.H. Robinson
CHRW
$17.5B
| $103K | ﹤0.01% |
11
| – | – |
|
|
2900
PUT
C.H. Robinson
CHRW
$17.5B
| $103K | ﹤0.01% |
11
| – | – |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.